Bioterrorism
Findings from Center for Cancer Research broaden understanding of bioterrorism
Published in Gene Therapy Weekly, July 26th, 2007
New investigation results, "Structure-assisted discovery of Variola major H1 phosphatase inhibitors," are detailed in a study published in Acta Crystallographica Section D. "Variola major virus, the causative agent of smallpox, encodes the dual-specificity H1 phosphatase. Because this enzyme is essential for the production of mature virus particles, it is an attractive molecular target for the development of therapeutic countermeasures for this potential agent of bioterrorism," scientists in the United States report.
"As a first step in this direction, the crystal structure of H1 phosphatase has been determined at a resolution of 1.8 A. In silico screening...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2007-07-26)
More Articles from Gene Therapy Weekly
- Gene Therapy
VIB scientist receives major research grant - Cancer Gene Therapy
Gene Therapy Eradicates Pancreatic Cancer in Preclinical Trial Targeting System's Success in Mouse Model Reported in Cancer Cell - Cancer Gene Therapy
Pure Chance or Is There a System? Computer Program to Uncover Non-Randomness in Genome Sequence Distribution - Cancer Gene Therapy
St. Jude Study Shows Temporary Improvement of Tumor Blood Flow Can Improve Chemotherapy - DNA Vaccines
Vical Reaches Initial Enrollment Milestone in Phase 2 Trial of DNA Vaccine Against CMV - Gene Therapy
AGTC Expands Its Clinical and Regulatory Expertise with Appointment of Jeffrey Chulay M.D. as Vice President and Chief Medical Officer - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
